Scandinavian ChemoTech AB (publ) (STO:CMOTEC.B)
Sweden · Delayed Price · Currency is SEK 3.800
+0.020 (0.53%)
At close: Mar 27, 2026
Scandinavian ChemoTech AB Market Cap
Scandinavian ChemoTech AB has a market cap or net worth of 96.73 million as of March 27, 2026. Its market cap has increased by 280.14% in one year.
Market Cap
96.73M
Enterprise Value
93.06M
Revenue
12.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.80
Market Cap Chart
Since December 6, 2016, Scandinavian ChemoTech AB's market cap has increased from 63.83M to 96.73M, an increase of 51.54%. That is a compound annual growth rate of 4.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 96.73M | -17.46% |
| Dec 30, 2025 | 117.19M | 180.45% |
| Dec 30, 2024 | 41.79M | -4.97% |
| Dec 29, 2023 | 43.97M | -27.52% |
| Dec 30, 2022 | 60.67M | -63.03% |
| Dec 30, 2021 | 164.08M | 100.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 6, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Simris Group AB (PUBL) | 133.63M |
| IRLAB Therapeutics AB | 128.26M |
| Xbrane Biopharma AB | 124.15M |
| Active Biotech AB | 114.67M |
| Alligator Bioscience AB | 106.53M |
| Biovica International AB | 105.09M |
| Annexin Pharmaceuticals AB | 98.12M |
| Alzinova AB | 91.12M |